Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03692429 |
|---|---|
| Brief Title: | alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (alloSHRINK) |
| First Submitted : | August 31, 2018 |
| First Submitted that Met QC Criteria : | October 1, 2018 |
| First Posted : | October 2, 2018 |
| Last Update Submitted that Met QC Criteria : | November 19, 2020 |
| Last Update Posted : | November 20, 2020 |